SCHEDULE 13G/A
Statement of Beneficial Ownership
Helus Pharma Inc. Filed Acc 0000947871-26-001034
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| ORBIMED CAPITAL LLC | 847,910 | 1.2% |
| ORBIMED ADVISORS LLC | 496,265 | 0.7% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…